{"count": 1, "results": [{"_id": "37630190", "pmid": 37630190, "pmcid": "PMC10459293", "title": "Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment", "journal": "Molecules", "authors": ["Yang MH", "Ho TC", "Chang CC", "Su YS", "Yuan CH", "Chuang KP", "Tyan YC"], "date": "2023-08-08T00:00:00Z", "doi": "10.3390/molecules28165938", "meta_date_publication": "2023 Aug 8", "meta_volume": "28", "meta_issue": "16", "meta_pages": "", "score": 50263.52, "text_hl": "Two types of angiotensin-converting enzyme (@GENE_AP2B1 @GENE_163 @@@ACE@@@) inhibitors, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_benazepril @CHEMICAL_MESH:C044946 @@@benazepril HCl@@@, were tested in @<m>DISEASE_Neuroblastoma</m> @DISEASE_MESH:D009447 @@@neuroblastoma@@@ cells and found to upregulate @GENE_LRP1B @GENE_53353 @@@low-density lipoprotein-receptor-related protein 1B@@@ (@GENE_LRP1B @GENE_53353 @@@LRP1B@@@) and @GENE_YWHAZ @GENE_7534 @@@14-3-3 protein zeta/delta@@@. ", "citations": {"NLM": "Yang MH, Ho TC, Chang CC, Su YS, Yuan CH, Chuang KP, Tyan YC. Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment Molecules. 2023 Aug 8;28(16):. PMID: 37630190", "BibTeX": "@article{37630190, title={Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment}, author={Yang MH and Ho TC and Chang CC and Su YS and Yuan CH and Chuang KP and Tyan YC}, journal={Molecules}, volume={28}, number={16}}"}}]}